International Journal of Gynecological Cancer
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
PR008/#179 Predictors of specialist palliative care access and impact on aggressiveness of end-of-life care: a population-based study of gynecologic cancer decedents in Ontario, Canada from 2006–2018
2024
-
Exploring the association between frailty and gynecologic cancer survivorship: a cross-sectional analysis of the Canadian longitudinal study on aging
2023
-
Predictors of lifetime cervical cancer screening and association with social determinants of health: cross-sectional evidence from the Canadian longitudinal study on aging
2023
-
34/#806 Patterns of palliative care utilization by women with gynecologic malignancies in Ontario, Canada: a 13-year population-based retrospective analysis
2022
-
EP418/#181 Outcomes of positive groin sentinel lymph node biopsies in vulvar squamous cell carcinoma and HPV status: a population based study
2022
-
2022-RA-295-ESGO Circulating cell free DNA and citrullinated histone H3 as useful biomarkers of NETosis in endometrial cancer
2022
-
2022-RA-744-ESGO Hepatitis B screening to reduce the risk of viral reactivation in gynecologic oncology patients receiving chemotherapy at a regional tertiary cancer centre: a quality improvement initiative
2022
-
2022-RA-747-ESGO Quality of end-of-life care and patterns of palliative care use by women with gynaecologic malignancies in Ontario, Canada: a 13-year population-based retrospective analysis
2022
-
2022-RA-933-ESGO Risk of venous thromboembolism and major bleeding in gynaecological cancer surgery: series of systematic reviews and meta-analyses
2022
-
EPV062/#354 Comparison of outcomes between abdominal, minimally invasive and combined vaginal- laparoscopic hysterectomy in patients with stage IAI/IA2 cervical cancer: 4C (Canadian cervical cancer collaborative) study
2021
-
EPV063/#357 The impact of surgical approach in cases with no residual disease on hysterectomy specimen: a 4C (Canadian cervical cancer collaborative) working group study
2021
-
EPV254/#148 Septuagenarians and octogenarians undergoing gynecologic oncology laparotomy: is there a role for routine postoperative cardiac biomarker monitoring?
2021
-
OP005/#352 Safety of vaginal hysterectomy for cervical cancer: a multicenter cohort study on behalf of the 4C (Canadian cervical cancer collaborative) working group
2021
-
657 Endocrine therapy in advanced endometrioid endometrial cancer: a retrospective analysis of clinicopathologic factors
2021
-
EP584 Circulating tumour DNA to monitor tumour activity in endometrial cancer
2019
-
EP610 Investigation of patient acceptability of ctDNA in endometrial cancer follow-up
2019
-
EP618 The use of preoperative imaging in endometrial cancer: are ontario physicians following GOC guidelines?
2019
-
P159 Human uterine cervix-on-a-chip: establishing the first in vitro model to study the development of cervical carcinoma and human papiloma virus mechanism of action
2019
-
Radiotherapy instead of inguinofemoral lymphadenectomy in vulvar cancer patients with a metastatic sentinel node: results of GROINSS-V II
2019
-
UNDIFFERENTIATED ENDOMETRIAL CANCER, A DIFFERENT ENTITY WITH AN AGGRESSIVE BEHAVIOR
2015
-
DOES GROIN NODE DISSECTION IN VULVAR CANCER DECREASE THE RISK OF GROIN RECURRENCE?
2014
-
TIME SERIES ANALYSIS OF GENETICS CONSULTATION FOR PATIENTS WITH SEROUS PELVIC CARCINOMA
2014
-
RANDOMISED DOUBLE-BLIND PHASE III TRIAL OF CEDIRANIB (AZD 2171) IN RELAPSED PLATINUM SENSITIVE OVARIAN CANCER: RESULTS OF THE ICON6 TRIAL.
2013
-
Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies
2005
-
Inguinofemoral sentinel lymph node biopsy by scar injection in vulvar cancer: an assessment of feasibility and long-term outcomes.
32:1512-1518.
2022
-
Brief family history questionnaire to screen for Lynch syndrome in women with newly diagnosed non-serous, non-mucinous ovarian cancers.
32:891-898.
2022
-
Gender imbalance in gynecologic oncology authorship and impact of COVID-19 pandemic.
32:583-589.
2022
-
The role of oophoropexy in patients with gynecological cancer who need radiation therapy.
32:380-388.
2022
-
Tumor site discordance in mismatch repair deficiency in synchronous endometrial and ovarian cancers.
30:1951-1958.
2020
-
Genetics Consultation Rates Following a Diagnosis of High-Grade Serous Ovarian Carcinoma in the Canadian Province of Ontario.
27:437-443.
2017
-
Oncologists’ Perceptions of Recurrent Ovarian Cancer Patients’ Preference for Participation in Treatment Decision Making and Strategies for When and How to Involve Patients in This Process.
25:1717-1723.
2015
-
Effectiveness of the Risk of Malignancy Index and the Risk of Ovarian Malignancy Algorithm in a Cohort of Women With Ovarian Cancer.
25:809-814.
2015
-
An Organizational Guideline for Gynecologic Oncology Services.
25:551-558.
2015
-
UNDIFFERENTIATED ENDOMETRIAL CANCER, A DIFFERENT ENTITY WITH AN AGGRESSIVE BEHAVIOR.
25:69-69.
2015
-
Further Insights Into Long-Term Trends in Relative Survival of Vulvar Cancer Patients: A Population-Based Study.
25:125-130.
2015
-
Cervical Cancer Incidence in Ontario Women: Differing Sociodemographic Gradients by Morphologic Type (Adenocarcinoma Versus Squamous Cell).
24:1341-1346.
2014
-
Performance Status and Symptom Scores of Women With Gynecologic Cancer at the End of Life.
23:971-978.
2013
-
Temporal Trends in the Relative Survival Among Women With Cervical Cancer in Canada: A Population-Based Study.
22:1208-1213.
2012
-
Characterizing the Learning Curve for Laparoscopic Radical Hysterectomy.
21:930-935.
2011
-
Teaching cervical cancer surgery in low- or middle-resource countries..
20:1604-1608.
2010
-
Assessment of outcomes in surgically staged I/II endometrial adenocarcinoma patients treated with postoperative vaginal vault radiotherapy only..
20:1356-1362.
2010
-
Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium.
20:787-793.
2010
-
Malignant Transformation Within Ovarian Dermoid Cysts.
20:75-81.
2010
-
cAMP response element–binding protein is expressed at high levels in human ovarian adenocarcinoma and regulates ovarian tumor cell proliferation.
18:1248-1257.
2008
-
Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review.
17:1194-1204.
2007
-
Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property.
16:1536-1544.
2006
-
Human ovarian cancer ascites fluid contains a mixture of incompletely degraded soluble products of fibrin that collectively possess an antiangiogenic property.
16:1536-1544.
2006
-
First-line treatment of ovarian/tubal/peritoneal cancer FIGO stage IIB-IV with paclitaxel/carboplatin with or without epirubicin (TEC vs TC). A gynecologic cancer intergroup study of the NSGO, EORTC GCG, and NCIC CTG. Results on progression-free survival.
15:221-221.
2005
-
Phase II multicenter open-label study of carboplatin and pegylated liposomal doxorubicin in uterine and cervical malignancies.
15:799-806.
2005
-
Steppe by steppe: gynecological oncology on the Mongolian plains.
15:359-360.
2005
-
Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy.
13:287-291.
2003
-
Phase II clinical trial of carboplatin and docetaxel in patients with metastatic ovarian cancer: Active combination with low incidence of peripheral neuropathy.
13:287-291.
2003
-
Desmoplastic small round cell tumor presenting in the ovaries: Report of a case and review of the literature.
12:760-763.
2002
-
A unique BRCA1 mutation identified in Mongolia.
11:241-243.
2001
-
Treatment of advanced ovarian carcinoma with carboplatin and paclitaxel in a patient with renal failure.
10:463-468.
2000
-
Flow cytometric assessment of DNA ploidy is a useful prognostic factor for patients with granulosa cell ovarian tumors.
1:227-232.
1991
has subject area
Identity
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)